News Detail
Indore, 5 Jan 2025: With the mandatory enforcement of the revised Schedule M manufacturing standards implemented from January 1, 2025, the Food and Drug Administration (FDA) department in collaboration with the Central Drugs Standard Control Organisation (CDSCO) has established a......
View Details
Source : The Times of India
Today news Indore
revised Schedule M compliance
pharmaceutical manufacturing standards
Indore pharmaceutical industry
Good Manufacturing Practices
FDA joint team
Related News
- AI eBay algorithm blocks two million illegal medicine sales (16-01-2025)
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)